IP Library Assignment 026903/0411
Patent Assignment
Reel/Frame 026903/0411

Assignment of Assignor's Interest

Recorded: 2011-09-14 Pages: 3
Assignor
ENGSTAD, ROLF EINAR
Executed: 2011-09-12
Assignee
BIOTEC PHARMACON ASA
DRAMMENSVEIEN 149, OSLO, 0277, NORWAY
Covered Property (1)
Therapy-Enhancing Glucan
Patent: 7,704,973 →
Application: 10/565,484 →
Publication: US 2006/0188506
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 7, 2006
From: CHEUNG, NAI-KONG V.
To: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Reel/Frame 017895/0359 →
Change of Name Feb 8, 2021
From: BIOTEC PHARMACON ASA
To: ARCTICZYMES TECHNOLOGIES ASA
Reel/Frame 055255/0701 →
Corrective Assignment to Correct the Inventor's Execution Date Previously Recorded at Reel: 055255 Frame: 0701. Assignor(S) Hereby Confirms the Change of Name. Mar 26, 2021
From: BIOTEC PHARMACON ASA
To: ARCTICZYMES TECHNOLOGIES ASA
Reel/Frame 056170/0779 →
Assignment of Assignor's Interest May 10, 2021
From: ARCTICZYMES TECHNOLOGIES ASA
To: BIOTEC BETAGLUCANS AS
Reel/Frame 056184/0376 →